CH625345A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625345A5 CH625345A5 CH684276A CH684276A CH625345A5 CH 625345 A5 CH625345 A5 CH 625345A5 CH 684276 A CH684276 A CH 684276A CH 684276 A CH684276 A CH 684276A CH 625345 A5 CH625345 A5 CH 625345A5
- Authority
- CH
- Switzerland
- Prior art keywords
- antibodies
- antigens
- aluminum hydroxide
- serum
- antigen
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 32
- 239000000427 antigen Substances 0.000 claims description 25
- 102000036639 antigens Human genes 0.000 claims description 25
- 108091007433 antigens Proteins 0.000 claims description 25
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims description 10
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims description 10
- 210000001124 body fluid Anatomy 0.000 claims description 10
- 239000010839 body fluid Substances 0.000 claims description 10
- 239000003463 adsorbent Substances 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 description 22
- 239000000203 mixture Substances 0.000 description 18
- 239000000872 buffer Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000013566 allergen Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229940074608 allergen extract Drugs 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 208000001840 Dandruff Diseases 0.000 description 7
- 230000000172 allergic effect Effects 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 5
- 229940024545 aluminum hydroxide Drugs 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229960004784 allergens Drugs 0.000 description 4
- 229940046528 grass pollen Drugs 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000746983 Phleum pratense Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001513 akia Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- -1 as mentioned Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK259875AA DK140815B (da) | 1975-06-10 | 1975-06-10 | Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625345A5 true CH625345A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1981-09-15 |
Family
ID=8113555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH684276A CH625345A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-06-10 | 1976-06-01 |
Country Status (15)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002980A1 (en) * | 1989-08-24 | 1991-03-07 | Ramsey Foundation | Method and apparatus for the measurement of organic antigens |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1549069A (en) * | 1976-12-10 | 1979-08-01 | Erba Farmitalia | Enzyme linked immunoassay |
| JPS5917388B2 (ja) * | 1979-02-22 | 1984-04-20 | 富士レビオ株式会社 | 間接凝集反応用吸収剤 |
| JPS56143955A (en) * | 1980-04-10 | 1981-11-10 | Fujirebio Inc | Method for diagnosis of initial infection of syphilis |
| EP0084531B1 (en) * | 1981-07-31 | 1987-05-20 | Mount Sinai School Of Medicine Of The City University Of New York | Assay for viruses |
| US4551431A (en) * | 1983-04-21 | 1985-11-05 | Phillips Petroleum Company | The use of gallium and indium salts for the immobilization of proteins |
| FR2832507B1 (fr) * | 2001-11-20 | 2004-02-20 | Stago Diagnostica | Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales |
| US7867715B2 (en) * | 2003-08-05 | 2011-01-11 | Alk-Abello A/S | Method of evaluating the immunological activity of a vaccine |
| WO2005022157A1 (en) * | 2003-08-05 | 2005-03-10 | Alk Abello A/S | Evaluation of adjuvanted vaccines |
| GB0607462D0 (en) * | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
| EP2344188B1 (en) * | 2008-10-02 | 2017-02-15 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
| US20100183675A1 (en) * | 2009-01-22 | 2010-07-22 | Allan Watkinson | Stable vaccine compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604135A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1967-09-26 | 1971-07-12 | ||
| JPS4849919A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1971-10-23 | 1973-07-14 | ||
| US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| US3776698A (en) * | 1972-01-24 | 1973-12-04 | Nuclear Med Lab | Test for thyroid hormone |
| NL7316346A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1972-12-11 | 1974-06-13 |
-
1975
- 1975-06-10 DK DK259875AA patent/DK140815B/da not_active IP Right Cessation
-
1976
- 1976-05-27 US US05/690,445 patent/US4127385A/en not_active Expired - Lifetime
- 1976-05-28 SE SE7606082A patent/SE427218B/xx not_active IP Right Cessation
- 1976-06-01 CH CH684276A patent/CH625345A5/de not_active IP Right Cessation
- 1976-06-02 DE DE2624814A patent/DE2624814C2/de not_active Expired
- 1976-06-04 FR FR7617016A patent/FR2314499A1/fr active Granted
- 1976-06-04 GB GB23206/76A patent/GB1503409A/en not_active Expired
- 1976-06-07 CA CA254,269A patent/CA1073352A/en not_active Expired
- 1976-06-09 NO NO761962A patent/NO147048C/no unknown
- 1976-06-09 LU LU75124A patent/LU75124A1/xx unknown
- 1976-06-09 NL NL7606248A patent/NL7606248A/xx not_active Application Discontinuation
- 1976-06-09 AU AU14753/76A patent/AU505801B2/en not_active Expired
- 1976-06-09 FI FI761640A patent/FI60319C/fi not_active IP Right Cessation
- 1976-06-10 JP JP51068175A patent/JPS51151323A/ja active Pending
- 1976-06-10 BE BE167819A patent/BE842821A/xx not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002980A1 (en) * | 1989-08-24 | 1991-03-07 | Ramsey Foundation | Method and apparatus for the measurement of organic antigens |
Also Published As
| Publication number | Publication date |
|---|---|
| AU505801B2 (en) | 1979-12-06 |
| DE2624814A1 (de) | 1976-12-23 |
| NO147048B (no) | 1982-10-11 |
| US4127385A (en) | 1978-11-28 |
| LU75124A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-01-24 |
| NL7606248A (nl) | 1976-12-14 |
| GB1503409A (en) | 1978-03-08 |
| FR2314499B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-08-13 |
| BE842821A (fr) | 1976-10-01 |
| FI60319C (fi) | 1981-12-10 |
| SE7606082L (sv) | 1976-12-11 |
| DK259875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-12-11 |
| SE427218B (sv) | 1983-03-14 |
| JPS51151323A (en) | 1976-12-25 |
| NO147048C (no) | 1983-01-19 |
| NO761962L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-12-13 |
| DE2624814C2 (de) | 1985-02-21 |
| FR2314499A1 (fr) | 1977-01-07 |
| AU1475376A (en) | 1977-12-15 |
| CA1073352A (en) | 1980-03-11 |
| FI60319B (fi) | 1981-08-31 |
| FI761640A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-12-11 |
| DK140815C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1980-04-08 |
| DK140815B (da) | 1979-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3590392C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69112610T2 (de) | Sammlung von analyten aus der mundhöhle für immunoassays. | |
| DE69218471T2 (de) | Verfahren zur Herstellung von biologisch aktiven Reagentien aus Succinimid enthaltenden Polymeren, analytisches Element und Verwendungsmethoden | |
| DE1598945A1 (de) | Verfahren zur Bestimmung von Proteinen und Polypeptiden | |
| DE3872500T2 (de) | Verwendung eines mit biotin verknuepften immobilisierten rezeptors in einer testvorrichtung, einem testsatz und einer methode zur bestimmung eines liganden. | |
| DE3882058T2 (de) | Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies. | |
| DE2560288C2 (de) | Probenhalter zur fluorometrischen Bestimmung von Substanzproben | |
| CH625345A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2653032A1 (de) | Radioimmun-nachweisverfahren fuer ein schilddruesenhormon und dafuer geeignetes reagens | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE2322562A1 (de) | Verfahren zur bestimmung eines oder mehrerer antigene in einer probe | |
| DE2604844C3 (de) | Verfahren zum Nachweis von Hepatitis B-Oberflächenantigen in menschlichem Blut | |
| DE2419884A1 (de) | Verfahren und vorrichtung zur bestimmung von trijodthyronin | |
| DE2523207C2 (de) | Verfahren zur Feststellung der Anwesenheit von Antikörpern | |
| DE3850379T2 (de) | Wasser-unlösliches Reagenz, dieses enthaltende Elemente und Verwendungsverfahren. | |
| EP0292809B1 (de) | Verfahren zur Bestimmung von Proteinen und Mittel dazu | |
| CH645726A5 (de) | Praeparat zur bestimmung von menschlichem immunoglobulin g, verfahren zu seiner herstellung und seine verwendung. | |
| DE3338759C1 (de) | Verfahren zum stabilen Binden von proteinischen Antigenen oder Allergenen an feste Traeger | |
| DE2533701A1 (de) | Immunologische diagnoseprodukte | |
| CH645727A5 (de) | Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung. | |
| DE2850950B2 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meflreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| DE2551576A1 (de) | Traeger fuer immunochemische messungen | |
| DE2641713A1 (de) | Immunfluoreszenz-nachweisverfahren in fester phase | |
| DE2054805B2 (de) | Indirekter Hämagglutinationstest bei gleichzeitiger Absorption heterologer Antikörper | |
| DE2025718B2 (de) | Verfahren zum Stabilisieren von lyophilisierten Erythrozyten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |